Determining the role of Panton-Valentine leukocidin in community-acquired methicillin-resistant Staphylococcus aureus pathogenesis
Year: 2008
Type: dissertation
Abstract: Community-Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA)\ninfections have reached alarming levels worldwide. There is an urgent need to identify\nmolecular markers to detect and develop treatment and prevention strategies against CAMRSA.\nCA-MRSA has been associated with the presence of a secreted toxin called\nPanton-Valentine leukocidin (PVL). The goal of the thesis project was to determine the\nrole of PVL as an indicator for CA-MRSA, to establish the effect of antibiotics on the\nsecretion of PVL, and to discuss the possible use of PVL as a target for antibody-based\ntherapy.\nThe results suggest that the presence ofPVL genes alone is not a reliable indicator\nfor CA-MRSA; a test for multiple genes may be required. PVL-secreting MRSA strains\nare more toxic to the human myeloid HL-60 cells than those that do not produce PVL.\nWhen the effect of antibiotics on PVL production was evaluated, subinhibitory\nconcentrations of antibiotics that inhibit protein synthesis, such as linezolid, clindamycin\nand rifampicin, decreased the production of PVL. Other antibiotics, such as vancomycin,\ndoxycycline, and tigecycline, did not affect PVL production at concentrations below the\nminimum inhibitory concentration. These results suggest that one or a combination of\nlinezolid, clindamycin and rifampicin antibiotics may be a better choice for inhibiting\nPVL production in CA-MRSA.\nFinally, polyclonal and several monoclonal antibodies were produced against\nPVL. These monoclonal antibodies can also be used to block PVL toxicity. Future\nexperiments can explore the possibility of using PVL as a potential target for the\ndevelopment of antibody based therapies aimed at preventing and treating the increasing\nnumbers of CA-MRSA infections.
Author: Rocha, Miguel Angel
Institution: California State University, Northridge
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7056012430
